Respiratory syncytial virus (RSV) is an important cause of disease in older adults.
Safety and immunogenicity of a stabilized RSV prefusion F subunit (RSVpreF) vaccine candidate with/without adjuvant in adults 65 - 85 years.
<h3>What are the results of Study of a Respiratory Syncytial Virus ?</h3>
All RSVpreF vaccine candidates elicited robust and persistent serum neutralizing responses when administered alone or with SIIV.
- There was no notable difference in neutralizing response between the formulations, including those containing CpG. In the Month 0,2 Cohort, there was no booster effect of dose 2.
- SIIV responses were similar or slightly lower with concomitant administration of RSVpreF. Most systemic and local reactions were mild and more frequent after RSVpreF than placebo.
Learn more about Respiratory Syncytial Virus here:
brainly.com/question/23764014
#SPJ4
sorry but where are the sentence to answer? can't see
Answer:
the results are published in a journal where studies are reviewed by other experts in the field.
Explanation:
the results are published in a journal where studies are reviewed by other experts in the field.
Answer:
u prolly go to hevan or hell.
Answer:
The a.nswer is smooth endoplasmic reticulum
Explanation:
The smooth endoplasmic reticulum is responsible for the synthesis of lipids (including phospholipids, cholesterol required for many hormones, ceramides, lipoproteins), calcium storage, and cell detoxification (in liver cells).
